FindTrial
Sign In

JY231 Injection

DRUG10 trials

Sponsors

920th Hospital of Joint Logistics Support Force of People's Liberation Army of China, Shenzhen Genocury Biotech Co., Ltd., Tongji Hospital, He Huang, Affiliated Hospital of Guangdong Medical University

Conditions

Autoimmune DiseasesAutoimmune Diseases of the Nervous SystemB Acute Lymphoblastic LeukemiaB-ALLB-NHLB-Non Hodgkin LymphomaB-cell MalignanciesSystemic Lupus Erythematosus (SLE)

Phase 1

JY231 Injection for the Treatment of Active Systemic Lupus Erythematosus (SLE)
RecruitingNCT06675422
920th Hospital of Joint Logistics Support Force of People's Liberation Army of ChinaSystemic Lupus Erythematosus (SLE)
Start: 2024-10-09End: 2026-12-31Target: 20Updated: 2024-11-05

Unknown Phase

JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia
RecruitingNCT06678282
Shenzhen Genocury Biotech Co., Ltd.B-ALL, B-NHL
Start: 2023-09-07End: 2026-12-31Target: 20Updated: 2024-11-07
JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia
RecruitingNCT06689917
Tongji HospitalB-ALL, B-NHL
Start: 2025-01-20End: 2026-12-31Target: 20Updated: 2025-07-08
JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders
RecruitingNCT06797024
Tongji HospitalAutoimmune Diseases of the Nervous System
Start: 2025-02-28End: 2027-03-31Target: 20Updated: 2025-05-31
JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell Lymphoma
Not yet recruitingNCT06879470
He HuangB-Non Hodgkin Lymphoma
Start: 2025-03-31End: 2027-12-31Target: 24Updated: 2025-03-17
JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia
RecruitingNCT06890065
Shenzhen Genocury Biotech Co., Ltd.B Acute Lymphoblastic Leukemia, B-Non Hodgkin Lymphoma
Start: 2025-03-01End: 2027-12-31Target: 20Updated: 2025-05-15
JY231(JY231) Injection for the Treatment of Refractory Autoimmune Diseases (ADs)
Not yet recruitingNCT06887985
He HuangAutoimmune Diseases
Start: 2025-03-31End: 2027-12-31Target: 45Updated: 2025-03-21
JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell Leukemia
Not yet recruitingNCT06902025
He HuangB-ALL
Start: 2025-03-31End: 2027-12-31Target: 24Updated: 2025-03-30
JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia
RecruitingNCT06940960
Affiliated Hospital of Guangdong Medical UniversityB Acute Lymphoblastic Leukemia, B-Non Hodgkin Lymphoma
Start: 2025-05-30End: 2027-12-31Target: 20Updated: 2025-06-10
JY231(JY231) Injection for the Treatment of R/R B-cell Malignancies
RecruitingNCT07065279
920th Hospital of Joint Logistics Support Force of People's Liberation Army of ChinaB-cell Malignancies
Start: 2025-07-31End: 2027-12-31Target: 36Updated: 2025-07-15